Prospective, multicenter, randomized, independent-group, open-label phase II study to investigate the efficacy and safety of three regimens with two doses of sagopilone as second-line therapy in patients with stage IIIB or IV non-small-cell lung cancer
Titel:
Prospective, multicenter, randomized, independent-group, open-label phase II study to investigate the efficacy and safety of three regimens with two doses of sagopilone as second-line therapy in patients with stage IIIB or IV non-small-cell lung cancer
Auteur:
Heigener, David F. von Pawel, Joachim Eschbach, Corinna Brune, Andreas Schmittel, Alexander Schmelter, Thomas Reck, Martin Fischer, Jürgen R.